Fermenta Biotech Ltd - 506414 - Notice Of NCLT Convened Meeting Of Equity Shareholders Of Fermenta Biotech Limited
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Equity Shareholders of Fermenta Biotech Limited dated July 30, 2022 was sent by way of courier and e-mail (to those shareholders whose email addresses are duly registered with the Company) on August 1, 2022 for seeking approval for the Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company') and their respective Shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The above Notice to Equity Shareholders of the Company was sent pursuant to the directions of the Hon''ble National Company Law Tribunal, Bench at Mumbai in order dated July 19, 2022.01-08-2022